Recent news
April 2010
Crucell, GSK partner to develop malaria vaccine candidate
Biotechnology company Crucell and pharmaceutical company GlaxoSmithKline (GSK) have announced that they will jointly develop a malaria vaccine candidate. The partnership is an extension of a 2003 agreement between Crucell, GSK, and the Walter Reed Army Institute of Research. See the links below for more information.
